DK1663287T3 - Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme - Google Patents
Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdommeInfo
- Publication number
- DK1663287T3 DK1663287T3 DK04764762T DK04764762T DK1663287T3 DK 1663287 T3 DK1663287 T3 DK 1663287T3 DK 04764762 T DK04764762 T DK 04764762T DK 04764762 T DK04764762 T DK 04764762T DK 1663287 T3 DK1663287 T3 DK 1663287T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- cyclosporins
- hcv diseases
- hcv
- modified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0320638.0A GB0320638D0 (en) | 2003-09-03 | 2003-09-03 | Organic compounds |
PCT/EP2004/009804 WO2005021028A1 (en) | 2003-09-03 | 2004-09-02 | Use of modified cyclosporins for the treatment of hcv disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1663287T3 true DK1663287T3 (da) | 2009-11-09 |
Family
ID=28686843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04764762T DK1663287T3 (da) | 2003-09-03 | 2004-09-02 | Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme |
Country Status (30)
Country | Link |
---|---|
US (1) | US7968518B2 (da) |
EP (2) | EP1663287B1 (da) |
JP (1) | JP4688806B2 (da) |
KR (1) | KR101116968B1 (da) |
CN (1) | CN1842343A (da) |
AU (2) | AU2004268382A1 (da) |
BR (1) | BRPI0414062B8 (da) |
CA (1) | CA2537137C (da) |
CY (1) | CY1110506T1 (da) |
DE (1) | DE602004022061D1 (da) |
DK (1) | DK1663287T3 (da) |
ES (1) | ES2328361T3 (da) |
GB (1) | GB0320638D0 (da) |
HK (1) | HK1091732A1 (da) |
HR (1) | HRP20090535T1 (da) |
IL (1) | IL173909A (da) |
IS (1) | IS2917B (da) |
MA (1) | MA28032A1 (da) |
MX (1) | MXPA06002394A (da) |
NO (1) | NO20061479L (da) |
NZ (1) | NZ545495A (da) |
PL (1) | PL1663287T3 (da) |
PT (1) | PT1663287E (da) |
RU (1) | RU2389501C2 (da) |
SG (1) | SG149063A1 (da) |
SI (1) | SI1663287T1 (da) |
TN (1) | TNSN06071A1 (da) |
TW (1) | TWI342782B (da) |
WO (1) | WO2005021028A1 (da) |
ZA (1) | ZA200601550B (da) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1091975E (pt) | 1998-07-01 | 2006-05-31 | Debiopharm Sa | Nova ciclosporina com um perfil de actividade melhorado |
GB0320638D0 (en) | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
GB0500020D0 (en) * | 2005-01-04 | 2005-02-09 | Novartis Ag | Organic compounds |
DE602005026294D1 (de) | 2004-07-14 | 2011-03-24 | Novartis Ag | Verwendung einer kombination von cyclosporin und pegylierten interferonen zur behandlung von hepatitis c (hcv) |
PL1793844T3 (pl) * | 2004-10-01 | 2011-05-31 | Debiopharm Sa | Zastosowanie [d-meala]3-[etval]4-cyklosporyny do leczenia zakażenia wirusem zapalenia wątroby typu c |
US7196161B2 (en) | 2004-10-01 | 2007-03-27 | Scynexis Inc. | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
KR101309409B1 (ko) * | 2004-10-01 | 2013-09-23 | 싸이넥시스, 인크. | C형 간염 바이러스 감염의 치료 및 예방을 위한 3-에테르및 3-티오에테르 치환된 시클로스포린 유도체 |
US7696167B2 (en) | 2004-11-22 | 2010-04-13 | Astellas Pharma Inc. | Cyclic peptide compound |
US7897565B2 (en) * | 2004-12-23 | 2011-03-01 | Novartis Ag | Compositions for HCV treatment |
NZ555142A (en) * | 2004-12-23 | 2010-03-26 | Novartis Ag | Compounds for flaviviridae treatment |
KR20080033274A (ko) | 2005-06-17 | 2008-04-16 | 노파르티스 아게 | Hcv에서 상글리페린의 용도 |
KR20080059270A (ko) * | 2005-09-30 | 2008-06-26 | 싸이넥시스, 인크. | C형 간염 감염의 치료 및 예방을 위한 방법 및 제약조성물 |
CN101316606B (zh) * | 2005-09-30 | 2015-05-27 | 西尼克斯公司 | 治疗和预防丙型肝炎感染的方法和药物组合物 |
CA2623864C (en) | 2005-09-30 | 2014-12-16 | Scynexis, Inc. | Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection |
AU2006306974B2 (en) | 2005-10-26 | 2011-09-22 | Astellas Pharma Inc. | New cyclic peptide compounds |
US7696165B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
US7696166B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
WO2007136759A2 (en) | 2006-05-19 | 2007-11-29 | Scynexis, Inc. | Method for the treatment and prevention of ocular disorders |
EP2027761A1 (fr) * | 2006-06-02 | 2009-02-25 | Claude Annie Perrichon | Gestion des electrons actifs |
BRPI0719189A2 (pt) * | 2006-10-12 | 2018-08-14 | Univ Kyushu Nat Univ Corp | uso de ciclosporinas modificadas |
WO2008069917A2 (en) * | 2006-11-20 | 2008-06-12 | Scynexis, Inc. | Novel cyclic peptides |
JP5801534B2 (ja) | 2007-01-04 | 2015-10-28 | デビオファーム インターナショナル ソシエテ アノニム | ウールリッヒ型先天筋ジストロフィーの処置のための、非免疫抑制性シクロスポリン |
US8603975B2 (en) * | 2007-05-02 | 2013-12-10 | Astellas Pharma Inc. | Cyclic peptide compounds |
WO2009028418A1 (ja) | 2007-08-24 | 2009-03-05 | Sapporo Medical University | シクロスポリンa結合タンパク質 |
WO2010002428A2 (en) * | 2008-06-06 | 2010-01-07 | Scynexis, Inc. | Novel macrocyclic peptides |
WO2009148615A1 (en) * | 2008-06-06 | 2009-12-10 | Scynexis, Inc. | Cyclosporin analogs and their use in the treatment of hcv infections |
BRPI0911709A2 (pt) * | 2008-07-30 | 2017-06-20 | Isotechnika Labs Inc | composto, processo para a produção de um composto, composição farmacêutica e método de tratar uma doença mediada a ciclofilina em um mamífero |
MX2011003259A (es) * | 2008-09-24 | 2011-04-21 | Astellas Pharma Inc | Compuesto de peptido y metodo para producir el mismo. |
BRPI0920502A2 (pt) * | 2008-11-06 | 2015-12-22 | Debio Rech Pharma Sa | compostos cicloundecadepsipeptídeos e seu uso como medicamento |
US8536114B2 (en) | 2008-12-31 | 2013-09-17 | Scynexis, Inc. | Macrocycles |
NZ594755A (en) | 2009-01-30 | 2013-12-20 | Enanta Pharm Inc | Cyclosporin analogues for preventing or treating hepatitis c infection |
US8481483B2 (en) | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
US8349312B2 (en) | 2009-07-09 | 2013-01-08 | Enanta Pharmaceuticals, Inc. | Proline substituted cyclosporin analogues |
US8367053B2 (en) | 2009-07-09 | 2013-02-05 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
US8685917B2 (en) | 2009-07-09 | 2014-04-01 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
WO2011063076A1 (en) | 2009-11-19 | 2011-05-26 | Itherx Pharmaceuticals, Inc. | Methods of treating hepatitis c virus with oxoacetamide compounds |
CN102869367A (zh) | 2009-12-09 | 2013-01-09 | 西尼克斯公司 | 新颖的环肽 |
US8623814B2 (en) | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
AU2011311706B2 (en) | 2010-10-05 | 2015-11-12 | Debiopharm S.A. | New treatments of Hepatitis C virus infection |
WO2012072655A1 (en) | 2010-11-30 | 2012-06-07 | Novartis Ag | New treatments of hepatitis c virus infection |
JO3337B1 (ar) | 2010-12-13 | 2019-03-13 | Debiopharm Sa | تركيبات صيدلية تشمل أليسبوريفير |
MY165152A (en) | 2010-12-15 | 2018-02-28 | Contravir Pharmaceuticals Inc | Cyclosporine analogue molecules modified at amino acid 1 and 3 |
CN103476409A (zh) | 2011-03-31 | 2013-12-25 | 诺华股份有限公司 | 治疗丙肝病毒感染的阿拉泊韦 |
KR20140010097A (ko) | 2011-04-01 | 2014-01-23 | 노파르티스 아게 | B형 간염 바이러스 단독 감염 또는 델타 간염 바이러스와의 조합 감염 및 연관된 간 질환의 치료 |
CN103648516A (zh) | 2011-04-13 | 2014-03-19 | 诺华股份有限公司 | 使用阿拉泊韦治疗丙型肝炎病毒感染 |
WO2013045460A1 (en) | 2011-09-27 | 2013-04-04 | Novartis Ag | Alisporivr for treatment of hepatis c virus infection |
AU2013259841A1 (en) | 2012-05-07 | 2014-10-30 | Novartis Ag | Pharmacokinetic modulation with alisporivir |
EP2855508B1 (en) | 2012-06-01 | 2018-02-14 | Allergan, Inc. | Cyclosporin a analogs |
US8906853B2 (en) | 2012-11-28 | 2014-12-09 | Enanta Pharmaceuticals, Inc. | [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection |
WO2015008223A1 (en) | 2013-07-17 | 2015-01-22 | Novartis Ag | Treatment of hepatitis c virus infection with alisporivir and ribavirin |
SG11201601274QA (en) | 2013-08-26 | 2016-03-30 | Enanta Pharm Inc | Cyclosporin analogues for preventing or treating hepatitis c |
WO2015136455A1 (en) | 2014-03-13 | 2015-09-17 | Novartis Ag | New treatments of hepatitis c virus infection |
WO2016073480A1 (en) | 2014-11-03 | 2016-05-12 | Enanta Pharmaceuticals, Inc. | Novel cyclosporin analogues for preventing or treating hepatitis c infection |
TW201639873A (zh) | 2015-01-08 | 2016-11-16 | 歐樂根公司 | Mebmt側鏈已環化之環孢菌素衍生物 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639724A (en) * | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US4917888A (en) | 1985-06-26 | 1990-04-17 | Cetus Corporation | Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation |
JP2514950B2 (ja) | 1986-03-10 | 1996-07-10 | エフ・ホフマン―ラ ロシユ アーゲー | 化学修飾蛋白質,その製造法および中間体 |
KR0148748B1 (ko) | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
SK278808B6 (sk) | 1990-11-02 | 1998-03-04 | Novartis Ag | Cyklosporíny, ich použitie pri príprave liečiva na |
US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
US5382657A (en) | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
US6174868B1 (en) * | 1992-09-10 | 2001-01-16 | Isis Pharmaceuticals, Inc. | Compositions and methods for treatment of hepatitis C virus-associated diseases |
EP0627406B1 (en) | 1992-10-21 | 1998-10-28 | Yoshitomi Pharmaceutical Industries, Ltd. | 2-amino-1,3-propanediol compound and immunosuppressant |
PT730470E (pt) | 1993-11-10 | 2002-08-30 | Enzon Inc | Conjugados melhorados de interferao-polimero |
DE69524962D1 (de) | 1994-08-22 | 2002-02-14 | Welfide Corp | Benzolderivate und deren medizinische verwendung |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
JP3786447B2 (ja) * | 1995-03-31 | 2006-06-14 | エーザイ株式会社 | C型肝炎の予防・治療剤 |
US5908621A (en) | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy |
FR2757522B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2757520B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent |
FR2757521B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
US6214873B1 (en) | 1997-04-04 | 2001-04-10 | Welfide Corporation | 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
JPH1180026A (ja) * | 1997-09-02 | 1999-03-23 | Yoshitomi Pharmaceut Ind Ltd | 新規免疫抑制剤、その使用方法およびその同定方法 |
GB9811854D0 (en) * | 1998-06-02 | 1998-07-29 | Ciba Geigy Ag | Organic compounds |
PT1091975E (pt) | 1998-07-01 | 2006-05-31 | Debiopharm Sa | Nova ciclosporina com um perfil de actividade melhorado |
KR100812578B1 (ko) | 2000-07-13 | 2008-03-13 | 상꾜 가부시키가이샤 | 아미노알코올 유도체 |
JP2004507552A (ja) | 2000-08-31 | 2004-03-11 | メルク エンド カムパニー インコーポレーテッド | 免疫調節剤としてのリン酸誘導体 |
WO2002032447A2 (en) | 2000-10-19 | 2002-04-25 | Fujisawa Pharmaceutical Co., Ltd. | Cell damage inhibitor |
JP2002125683A (ja) * | 2000-10-27 | 2002-05-08 | Tokyoto Igaku Kenkyu Kiko | インターフェロンの有効性を予測する方法並びにそれに用いられるプライマー及びプローブ |
ATE314383T1 (de) | 2001-03-26 | 2006-01-15 | Novartis Pharma Gmbh | 2-amino-propanol derivate |
JP2002316985A (ja) | 2001-04-20 | 2002-10-31 | Sankyo Co Ltd | ベンゾチオフェン誘導体 |
DE60235900D1 (de) | 2001-09-27 | 2010-05-20 | Kyorin Seiyaku Kk | Osuppressivum |
KR100913269B1 (ko) | 2001-09-27 | 2009-08-21 | 교린 세이야꾸 가부시키 가이샤 | 디아릴 황화물 유도체, 그의 염 및 이를 이용한 면역억제제 |
ATE441654T1 (de) | 2002-01-18 | 2009-09-15 | Merck & Co Inc | Edg-rezeptoragonisten |
EP1575964B1 (en) | 2002-01-18 | 2009-11-11 | Merck & Co., Inc. | N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
US20030213603A1 (en) * | 2002-05-14 | 2003-11-20 | Fisher David B. | Dual use extension apparatus for a tool |
KR20050035194A (ko) | 2002-06-28 | 2005-04-15 | 이데닉스 (케이만) 리미티드 | 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘 |
GB0313444D0 (en) | 2003-06-11 | 2003-07-16 | Midland Medical Technologies L | Modular dysplasia cup |
GB0320638D0 (en) | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
PL1793844T3 (pl) | 2004-10-01 | 2011-05-31 | Debiopharm Sa | Zastosowanie [d-meala]3-[etval]4-cyklosporyny do leczenia zakażenia wirusem zapalenia wątroby typu c |
US7897565B2 (en) | 2004-12-23 | 2011-03-01 | Novartis Ag | Compositions for HCV treatment |
-
2003
- 2003-09-03 GB GBGB0320638.0A patent/GB0320638D0/en not_active Ceased
-
2004
- 2004-09-02 SI SI200431200T patent/SI1663287T1/sl unknown
- 2004-09-02 KR KR1020067004342A patent/KR101116968B1/ko active IP Right Grant
- 2004-09-02 PT PT04764762T patent/PT1663287E/pt unknown
- 2004-09-02 CN CNA2004800246044A patent/CN1842343A/zh active Pending
- 2004-09-02 AU AU2004268382A patent/AU2004268382A1/en not_active Abandoned
- 2004-09-02 CA CA2537137A patent/CA2537137C/en not_active Expired - Fee Related
- 2004-09-02 WO PCT/EP2004/009804 patent/WO2005021028A1/en active Application Filing
- 2004-09-02 JP JP2006525712A patent/JP4688806B2/ja not_active Expired - Fee Related
- 2004-09-02 US US10/570,097 patent/US7968518B2/en active Active
- 2004-09-02 DE DE602004022061T patent/DE602004022061D1/de active Active
- 2004-09-02 SG SG200809555-6A patent/SG149063A1/en unknown
- 2004-09-02 EP EP04764762A patent/EP1663287B1/en active Active
- 2004-09-02 EP EP06125649.1A patent/EP1797892B1/en active Active
- 2004-09-02 MX MXPA06002394A patent/MXPA06002394A/es active IP Right Grant
- 2004-09-02 NZ NZ545495A patent/NZ545495A/en not_active IP Right Cessation
- 2004-09-02 PL PL04764762T patent/PL1663287T3/pl unknown
- 2004-09-02 RU RU2006110533/15A patent/RU2389501C2/ru not_active IP Right Cessation
- 2004-09-02 DK DK04764762T patent/DK1663287T3/da active
- 2004-09-02 BR BRPI0414062A patent/BRPI0414062B8/pt not_active IP Right Cessation
- 2004-09-02 TW TW093126578A patent/TWI342782B/zh not_active IP Right Cessation
- 2004-09-02 ES ES04764762T patent/ES2328361T3/es active Active
-
2006
- 2006-02-22 ZA ZA200601550A patent/ZA200601550B/en unknown
- 2006-02-23 IL IL173909A patent/IL173909A/en active IP Right Grant
- 2006-03-02 TN TNP2006000071A patent/TNSN06071A1/en unknown
- 2006-03-10 MA MA28865A patent/MA28032A1/fr unknown
- 2006-03-24 IS IS8371A patent/IS2917B/is unknown
- 2006-03-31 NO NO20061479A patent/NO20061479L/no not_active Application Discontinuation
- 2006-11-09 HK HK06112329.1A patent/HK1091732A1/xx not_active IP Right Cessation
-
2008
- 2008-07-09 AU AU2008203031A patent/AU2008203031B2/en not_active Ceased
-
2009
- 2009-09-16 CY CY20091100955T patent/CY1110506T1/el unknown
- 2009-10-05 HR HR20090535T patent/HRP20090535T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1663287T3 (da) | Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme | |
DK1944322T3 (da) | Behandling af TNFalfa-relaterede sygdomme | |
CY2016035I2 (el) | Θεραπευτικη χρηση αντισωματων anti-cs1 | |
DK1716162T3 (da) | Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme | |
DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
DK1701941T3 (da) | Forbindelser til behandling af sygdomme med celleproliferation | |
DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
FI20060154A (fi) | Neurogeneratiivisten tilojen hoito | |
DK2308507T3 (da) | Fremgangsmåder til behandling af præeklampsi | |
DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
DE602004018587D1 (de) | Staubschützende Wegwerfmaske | |
DK1720571T3 (da) | Fremgangsmåde til behandling af hæmolytisk sygdom | |
DK1556342T3 (da) | Phenethanolaminderivat til behandling af respiratoriske sygdomme | |
DK1656346T3 (da) | 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme | |
DK1575597T3 (da) | Anvendelse af rimexolon til behandling af öjentörhed | |
DK1592384T3 (da) | Cop 1 til behandling af inflammatoriske tarmsygdomme | |
DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
DK1744781T3 (da) | Behandling af infektionssygdomme | |
DK1638502T3 (da) | Dentalt behandlingselement | |
DK3332789T3 (da) | Cladribinkur til behandling af multipel sklerose | |
DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
DK1727801T3 (da) | Til behandling af smerter anvendelige piperaziner | |
DK1670482T4 (da) | Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme | |
DK1597171T3 (da) | Terapeutisk mikroskum |